Skip to main content
Article
Effective treatment of scrotal lichen simplex chronicus with 0.1% tacrolimus ointment: an observational study
Journal of the European Academy of Dermatology and Venereology (2014)
  • Eugene ST Tan
  • Andy SL Tan, University of Pennsylvania
  • Hongliang Tey
Abstract

Anogenital lichen simplex chronicus (LSC) poses a therapeutic challenge as conventional treatment with topical steroids often yields unsatisfactory itch relief, and is limited by the risk of steroid atrophy. Tacrolimus is a calcineurin inhibitor that is effective in treating a wide range of chronic inflammatory dermatoses with an excellent safety profile. To the best of our knowledge, there are no prior published studies on the treatment of scrotal LSC. Our aim was to evaluate the efficacy of topical 0.1% tacrolimus ointment in the treatment of scrotal LSC.

Keywords
  • scrotal lichen simplex chronicus,
  • tacrolimus,
  • observational study
Publication Date
2014
Citation Information
Eugene ST Tan, Andy SL Tan and Hongliang Tey. "Effective treatment of scrotal lichen simplex chronicus with 0.1% tacrolimus ointment: an observational study" Journal of the European Academy of Dermatology and Venereology (2014)
Available at: http://works.bepress.com/andysltan/16/